Mats Gunnar Pettersson

Direktor/Vorstandsmitglied bei MAGLE CHEMOSWED HOLDING AB

78 Jahre

Health Technology

Commercial Services

Distribution Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Hans Henrik Lidgard	M	78	MAGLE CHEMOSWED HOLDING AB Magle AB Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The company is based in Lund, Sweden. Magle Chemoswed AB Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The company is based in Lund, Sweden.	30 Jahre
Sven-Christer Nilsson	M	79	MAGLE CHEMOSWED HOLDING AB Magle Chemoswed AB Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The company is based in Lund, Sweden.	8 Jahre
Justin Pierce	M	51	MAGLE CHEMOSWED HOLDING AB Magle AB Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The company is based in Lund, Sweden. Magle Chemoswed AB Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The company is based in Lund, Sweden.	9 Jahre
Lars Søren Rasmussen	M	65	H. LUNDBECK A/S	11 Jahre
Erik Dahl	M	-	PHOTOCURE ASA	12 Jahre
Deirdre Connelly	F	63	GENMAB A/S	7 Jahre
Rolf K. Hoffmann	M	64	GENMAB A/S	8 Jahre
Marisol Peron	F	-	GENMAB A/S	5 Jahre
Pernille Erenbjerg	F	57	GENMAB A/S	9 Jahre
Paolo Augusto Paoletti	M	73	GENMAB A/S	9 Jahre
Tahamtan Ahmadi	M	51	GENMAB A/S	7 Jahre
Martin Lidgard	M	47	MAGLE CHEMOSWED HOLDING AB	3 Jahre
Ingela Fritzon	M	60	MAGLE CHEMOSWED HOLDING AB	5 Jahre
Malin Malmsjö	M	51	MAGLE CHEMOSWED HOLDING AB	8 Jahre
Fredrik Andersson	M	48	MAGLE CHEMOSWED HOLDING AB	25 Jahre
Petra Sjölin	F	-	MAGLE CHEMOSWED HOLDING AB	4 Jahre
Helena Ossmer Thedius	M	48	MAGLE CHEMOSWED HOLDING AB	2 Jahre
Anthony Mancini	M	53	GENMAB A/S	4 Jahre
Mijke Zachariasse	M	51	GENMAB A/S	5 Jahre
Mark Beveridge	M	46	MOBERG PHARMA AB	9 Jahre
Simon Jegou	M	-	MAGLE CHEMOSWED HOLDING AB	2 Jahre
Judith Klimovsky	M	67	GENMAB A/S	7 Jahre
Joel Magnus Eklund	M	44	MAGLE CHEMOSWED HOLDING AB	4 Jahre
Andrew Carlsen	M	-	GENMAB A/S	5 Jahre
Claudia Lindwall	F	61	MAGLE CHEMOSWED HOLDING AB	3 Jahre

Mehr sehen

Beziehungs-Chart

Beziehungen zu mehreren Unternehmen

Ehemalige Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Sven Håkan Björklund	M	68	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. H. LUNDBECK A/S	12 Jahre
Geert Cauwenbergh	M	70	MOBERG PHARMA AB ABLYNX	12 Jahre
Alf Gunnar Martin Nicklasson	M	69	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	3 Jahre
Carl Johan Kördel	M	62	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.	6 Jahre
Russell Greig	M	71	ABLYNX	-
Thomas Lennart Eklund	M	57	MOBERG PHARMA AB	4 Jahre
Wenche Nelly A. Rolfsen Sandsborg	M	72	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	8 Jahre
Hans Henrik Munch-Jensen	M	64	GENMAB A/S H. LUNDBECK A/S	17 Jahre
Christian Fekete	M	63	PHOTOCURE ASA	7 Jahre
Andreas Eggert	M	56	H. LUNDBECK A/S	5 Jahre
Peter Henrik Kürstein-Jensen	M	68	H. LUNDBECK A/S	11 Jahre
Remi Vermeiren	M	84	ABLYNX	-
Rachel Curtis Gravesen	F	55	GENMAB A/S	8 Jahre
Synne Hermansen Røine	F	45	PHOTOCURE ASA	6 Jahre
Mattias Klintemar	M	57	MOBERG PHARMA AB	-
Kathleen Deardorff	M	65	PHOTOCURE ASA	5 Jahre
Bente-Lill Romøren	F	75	PHOTOCURE ASA	-
Bo-Gunnar Rosenbrand	M	61	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	9 Jahre
Ulf Arne Wiinberg	M	66	H. LUNDBECK A/S	6 Jahre
Daniel John Bruno	M	45	GENMAB A/S	-
Anders Götzsche	M	56	H. LUNDBECK A/S	15 Jahre
Roger Perlmutter	M	71	ABLYNX	1 Jahre
Xavier Yon	M	84	PHOTOCURE ASA	-
Sylvain Forget	M	58	SWEDISH ORPHAN BIOVITRUM AB	-
Catarina Larsson	F	72	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	9 Jahre
Melanie Lee	M	65	H. LUNDBECK A/S	3 Jahre
Tom Edward Pike	M	64	PHOTOCURE ASA	6 Jahre
Lena Nyström	F	68	SWEDISH ORPHAN BIOVITRUM AB	-
Eva Steiness	M	83	PHOTOCURE ASA	-
Jens Peter Balling	M	-	H. LUNDBECK A/S	-
Jonathan Peacock	M	66	GENMAB A/S	1 Jahre
Torbjörn Wärnheim	M	66	MOBERG PHARMA AB	7 Jahre
Claus Tycho Bræstrup	M	79	H. LUNDBECK A/S	10 Jahre
Hans Lennart Rudolf Wigzell	M	86	SWEDISH ORPHAN BIOVITRUM AB	-
Thomas Bjerregaard Thomsen	M	54	MOBERG PHARMA AB	4 Jahre
Anders Edvell	M	55	SWEDISH ORPHAN BIOVITRUM AB	-
Burt Malkiel	M	90	GENMAB A/S	11 Jahre
Iman Barilero	M	-	H. LUNDBECK A/S	-
Kristian Sibilitz	M	-	H. LUNDBECK A/S	-
Barbara Jaszewski	F	65	H. LUNDBECK A/S	-
Ken Friis	M	63	H. LUNDBECK A/S	5 Jahre
Cecilia Förberg	M	68	SWEDISH ORPHAN BIOVITRUM AB	-
João Carlos Nunes Rocha	M	66	H. LUNDBECK A/S	-
Jan Miller	M	54	H. LUNDBECK A/S	11 Jahre
Henrik Sindal Jensen	M	55	H. LUNDBECK A/S	-
Peter Storm Kristensen	M	49	GENMAB A/S	-
An van Es-Johansson	M	64	SWEDISH ORPHAN BIOVITRUM AB	13 Jahre
Steen Lisby	M	60	GENMAB A/S	9 Jahre
Tugba Ceylan	F	-	H. LUNDBECK A/S	1 Jahre
Rima Bawarsh Nassar	M	70	GENMAB A/S	-
Suba Krishnan	M	59	GENMAB A/S	1 Jahre
Jes Trygved	M	51	H. LUNDBECK A/S	3 Jahre
Teddy Hebo Larsen	M	71	H. LUNDBECK A/S	4 Jahre
Helle Størum	F	57	H. LUNDBECK A/S	9 Jahre
Markus Thor	M	53	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.	8 Jahre
Thorleif Krarup	M	71	H. LUNDBECK A/S	11 Jahre
Michael Steinmetz	M	75	SWEDISH ORPHAN BIOVITRUM AB	10 Jahre
Erik Engebretsen	M	76	PHOTOCURE ASA	10 Jahre
Christian Peter Dyvig	M	59	H. LUNDBECK A/S	4 Jahre
Göran Arvidson	M	64	SWEDISH ORPHAN BIOVITRUM AB	16 Jahre
Fredrik Berg	M	69	SWEDISH ORPHAN BIOVITRUM AB	-
Håkan Åström	M	77	SWEDISH ORPHAN BIOVITRUM AB	9 Jahre
Jes Christian Wibroe Østergaard	M	76	H. LUNDBECK A/S	-
George Aitken-Davies	M	46	MOBERG PHARMA AB	2 Jahre
Stig Lökke Pedersen	M	62	H. LUNDBECK A/S	19 Jahre
Inge Holm Lauritzen	F	57	H. LUNDBECK A/S	9 Jahre
Flemming Bent Lindeløv	M	75	H. LUNDBECK A/S	-
Peter Anastasiou	M	53	H. LUNDBECK A/S	12 Jahre
Maria Berggren	F	63	SWEDISH ORPHAN BIOVITRUM AB	-
Egil Bodd	M	69	H. LUNDBECK A/S	-
Paul W. H. I. Parren	M	60	GENMAB A/S	16 Jahre
Anders Martin-Löf	M	53	SWEDISH ORPHAN BIOVITRUM AB	1 Jahre
Klaus Bæk Simonsen	M	-	H. LUNDBECK A/S	-
Maj-Britt Kaltoft	M	61	H. LUNDBECK A/S	5 Jahre
Niels Svenstrup	M	54	H. LUNDBECK A/S	7 Jahre

Statistik

Land	Beziehungen	% des Gesamten
Dänemark	51	51,00%
Schweden	31	31,00%
Norwegen	9	9,00%
Vereinigte Staaten	7	7,00%
Belgien	4	4,00%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen